Entero Therapeutics, Inc. (ENTO NASDAQ) stock market data APIs
$3.5751
0.01(0.3%)
as of January 22, 2026
Try our APIs with
free plan!
Entero Therapeutics, Inc. Financial Data Overview
Price chart is built with
Anychart
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom with additional offices in Prague, Czechia; and Mississauga, Canada.
Prev. Close
3.5751
Open
3.5859
High
3.6212
Low
3.3459
52 wk Range
0.969-5.84
Market Cap
10 052 K
Shares Outstanding
3 362 K
EPS
-0.7524
Beta
1.145
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Entero Therapeutics, Inc. data using free add-ons & libraries
Get Entero Therapeutics, Inc. Fundamental Data
Entero Therapeutics, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -4 582 129
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-20
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Entero Therapeutics, Inc. News
New
Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb
(RTTNews) - Several small-cap biotech and healthcare stocks posted notable gains in after-hours trading on Friday, November 28, 2025, despite limited fresh news flow. Below is a roundup of the key mov...
Entero's Grid AI Announces Major U.S. Expansion and Incoming Leadership to Accelerate AI Infrastructure Strategy
BOCA RATON, FL / ACCESS Newswire / November 19, 2025 / Entero Therapeutics, Inc. ("Entero") today announced that its wholly owned subsidiary, Grid AI, is finalizing the formation of a U.S.-based execu...
Entero Therapeutics, Inc. (ENTO) Names Jason D. Sawyer as New CEO Amid Strategic Shift
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. Entero Therapeutics, Inc. is included in them. Entero Therapeutics, Inc. (NASDAQ:ENTO) is a clini...
Which stocks are experiencing notable movement on Friday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS ...
Get Entero Therapeutics, Inc. fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
